Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Ikterus obstruktif merupakan salah satu komplikasi tersering keganasan sistem bilier. Keadaan ini akan memicu pelepasan sitokin proinflamasi. Terdapat kontroversi mengenai pengaruh drainase bilier terhadap perubahan kadar sitokin proinflamasi pada penderita kanker pankreatobilier.Tujuan: Untuk mengetahui kadar Tumor Necrosis Faktor alfa (TNF-alfa) dan Interleukin 6 (IL6) sebelum dan sesudah Endoscopic Retrograde Cholangio Pancreatography (ERCP) atau Percutaneus Transhepatic Biliary Drainage (PTBD) pada penderita ikterus obstruksi etiologi kanker pankreatobilier.Metode: Desain penelitian adalah one group before after study. Pemilihan sampel secara consecutive sampling. Sampel darah diambil sebelum dan lima hari sesudah ERCP atau PTBD. Pengukuran kadar TNF-alfa dan IL-6 dengan cara Enzyme Linked Immunosorbed Assay (ELISA).Hasil: Terdapat 40 orang responden yang diikutsertakan dalam penelitian ini, 22 laki laki dan 18 perempuan dengan usia rata rata 55,3 tahun. Berdasarkan imaging dan endoskopi, ditegakkan diagnosis kolangiokarsinoma sebanyak 22 orang, tumor ampula Vateri 10 orang, dan tumor pankreas 8 orang. Kadar rata-rata TNF- alfa sebelum tindakan 4,81 (2,91) pg/ml dan sesudah tindakan 8,05 (6,7) pg/ml, terdapat peningkatan yang bermakna setelah tindakan drainase bilier (p:0,02). Kadar rata-rata IL-6 sebelum tindakan 7,79 (1,57) pg/ml dan sesudah tindakan 7,75 (1,76) pg/ml, tidak terdapat perbedaan yang bermakna setelah tindakan drainase bilier (p:0.52). Kadar rata-rata bilirubin sebelum tindakan 15,5 mg% dan sesudah tindakan 11,3 mg%.Simpulan: Terjadi peningkatan kadar rata-rata TNF-alfa secara bermakna setelah drainase. Tidak ada penurunan yang bermakna kadar rata-rata IL-6.

---

Background: Obstructive jaundice represents the most common complication of biliary tract malignancy. Obstructive jaundice causes releases of proinflammatory cytokine. There has been controversy about effect of biliary drainage on the change in proinflammatory cytokine level in pancreatobiliary cancer patients.Objective: The present study was designed to determine levels of Tumor Necrosis Factor Alpha (TNF-Alpha) and Interleukin 6 (IL-6) in preprocedure of either Endoscopic Retrograde Cholangio Pancreatography (ERCP) or Percutaneus Transhepatic Biliary Drainage (PTBD) and postprocedure of them in obstructive jaundice patient caused by pancreatobiliary cancer.Methods : The study method is before- and- after case study design with consecutive sampling. Blood was collected five days prior to either Endoscopic Retrograde Cholangio Pancreatography (ERCP) procedure or Percutaneus Transhepatic Biliary Drainage (PTBD) procedure and five days after either of them. Enzyme Linked Immunosorbed Assay (ELISA) was used to determine TNF-Alpha and IL-6.Results: Forty subjects were included in this study which consisted of 22 men and 18 women. The mean age was 55.3 years old. According to the results of imaging and endoscopy procedure, twenty two (22) people were diagnosed cholangi carcinoma, ten (10) people were diagnosed ampulla varteri and eigth (8) people were diagnosed pancreatic tumor. In preprocedure, the mean of TNF-Alpha concentration was 4.81 (2.91) pg/mL, the mean of IL-6 concentration was 7.79 (1.57) pg/mL and the mean of bilirubin concentration was 15.5 mg%. In postprocedure, the mean of TNF-Alpha concentration was 8.05 (6.7) pg/mL, there was significant increase in TNF-Alpha concentration (p:0.02). However, the mean of IL-6 concentration was 7.75 (1.76) pg/mL, there was not any significant chance in IL-6 concentration (p:0.52). The mean of bilirubin concentration was 11.3 mg%.Conclusions: On one hand, there was significant increase in mean concentration value of TNF-Alpha after biliary drainage procedure. On the other hand there was not any significant decrease in mean concentration value of IL-6 after biliary drainage procedure."

"Chalangiocarcinoma is the second most common primary liver malignancy with global increase of incidence and mortality. The mean age at presentation is 50 years. Patients with cholangiocarcinoma usually will have symptoms of obstructive jaundice followed with supporting laboratory and imaging findings. The predominant clinical feature of extrahepatic cholangiocarcinoma is biliary obstruction resulting in Jaundice; while intrahepatic cholangiocarcinoma causes symptoms of intrahepatic mass including abdominal pain in right upper quadrant and other tumor-related symptoms such as cachexia and malaise. The diagnosis and staging of cholangiocarcinoma require multidisciplinary approaches including laboratory, radiological, endoscopic approaches and analysis on pathology. This case report describes a patient with a cholangiocarcinoma based on result of endoscopic retrograde cholangiopancreatography (ERCP) imaging. In addition to a diagnosis tool, ERCP can also be a therapeutic modality for placing stent to reduce symptoms of cholestasis. There were supporting laboratory findings such as increased bilirubin level, alkaline phosphates (ALP) and gamma glutamyltransferase (GGT) levels as well as increased level of tumor markers such as carcinoembryonic antigen (CEA), carbohydrate antigen (CA 19-9 and cytological examination."

"Background: Tire methods of ERCP have been used for diagnostic and therapeutic purposes to pass bile fluid and extract stones from the bite duct in patients with obstructive extrahepatic jaundice.

Method: A retrospective study was performed on patients with obstructive extrahepatic jaundice patients who underwent ERCP dttring a two-years time period from January 1999 to December 2000. ERCP was performed with a premedication of I0 mg midazolam, followed by a chollangiography contrast containing 1 mg/dl of Garamicin and 25 mg of Pethidine if sphincterotomy was performed.

Results: From 126 patients with obstructive extrahepatic jaundice treated with ERCR the male to female ratio was 1.86:1. The majority of the (group) of patients were between 51-60 years of age (33.3 % ). The youngest patient (group) was 24 years and the oldest 97 years. The diagnostic study found the following cases: normal 3 cases (28%), bile duct stone 46 cases (43.4%) carcinoma of ampula voter 20 cases (18.9%), CBD tumor 7 crises (6.6%), carcinoma of head of pancreas 2 cases (1.9%), diverticle 4 cases (38%), duodenal tumor I case (0.9%), carcinoma of ampula vater and bite duct stone 1 case (0.9%), SOD 5 cases (4.7%), CBD stricture 1 case (0.9%) and failure I6 cases (15.1%). The patients received the following treatment: sphyncterotomy 36 cases (51 .4%), stent application 11 cases (15.7%), sphincterotomy with stent 18 cases (25.7%) and basket method 5 cases ( 7. 1%)."

"ABSTRAKLatar belakang: Mengetahui faktor-faktor yang berhubungan dengan mortalitas pada pasien ikterus obstruktif dengan etiologi maligna merupakan hal penting untuk membantu membuat perencanaan optimal dalam melakukan pendekatan terapi yang tepat untuk masing-masing etiologi dan faktor terkait guna membantu meningkatkan kesintasan dan kualitas hidup pasien.Tujuan: Mendapatkan kesintasan dan faktor-faktor yang berhubungan dengan mortalitas pada pasien ikterus obstruktif dengan etiologi maligna di RSCM.Metode: Penelitian kohort retrospektif dan prospektif dilakukan dengan data sekunder pasien ikterus obstruktif yang dirawat di ruang perawatan RSCM antara Januari 2010 ? Desember 2013. Faktor-faktor yang dinilai meliputi umur, jenis kelamin, sepsis, hipoalbumin, tingkat bilirubin serum, tingkat CA 19-9 serum, drainase bilier, keganasan non ca ampula Vater, dan komorbid dengan hasil keluaran berupa mortalitas pasien. Kesintasan kumulatif terjadinya mortalitas dalam 3 bulan setelah diagnosis dinyatakan dengan kurva Kaplan Meier. Analisis bivariat dan multivariat dilakukan dengan Cox Proportional Hazards Regression Model untuk mendapatkan Hazard Ratio (HR) dari setiap faktor prognosis. Skor prognosis dari setiap faktor bermakna ditentukan berdasarkan model akhir regresi.Hasil: Sebanyak 181 dari 402 pasien ikterus obstruktif dengan etiologi maligna memenuhi kriteria penelitian dengan proporsi laki-laki sebesar 58,6 % dengan pasien berumur ≥ 50 tahun sebesar 57,5 %. Sepsis (HR 2.462 ; IK 95% 1.552 ? 3.906), drainase bilier tidak berhasil/tidak ada (HR 1.604 ; IK 95% 0.988 ? 2.603), serta skor indeks komorbid Charlson ≥ 4 (HR 2.476 ; IK 95% 1.562 ? 3.923) merupakan faktor prognosis yang bermakna terhadap mortalitas pasien. Median kesintasan pasien dengan faktor prognosis bermakna 14 hari; IK 95% 9.66 ? 18.34 sedangkan median kesintasan keseluruhan 26 hari; IK 95% 20.82 ? 31.19 (p < 0.01). Ambang skor prognostik terbaik didapatkan pada skor ≥ 2 dengan sensitifitas 68% dan spesifisitas 75%. AUC pada kurva ROC 0.769.Kesimpulan: Kesintasan pasien dengan faktor prognosis sepsis, drainase bilier tidak berhasil/tidak ada, dan skor indeks komorbid Charlson ≥ 4 lebih pendek dibandingkan kesintasan keseluruhan pasien. Skor prognostik ≥ 2 termasuk dalam risiko tinggi kematian dan kemampuan prediksi mortalitas dari faktor prognosis bermakna sebesar 76.9%.

---

ABSTRACT

Background: Understanding any related factors affecting mortality in patients with malignant obstructive jaundice will better guide to an approriate and optimal planning in making theurapetic approach for each etiological and relating factors thus improving survival and patients? quality of life.

Aim: To obtain survival rate and mortality-related factors of malignant obsructive jaundice patients in Cipto Mangunkusumo Hospital.

Methods: Retrospective-prospective cohort study was conducted with medical records of obstructive jaundice inpatient from January 2010 to December 2013 were reviewed. Suggested mortality-related factors include age, gender, sepsis, hypoalbumin, serum bilirubin level, serum CA 19-9 level, billiary drainage, non-ampulla Vateri carcinoma, and comorbid were analyzed. Three-month cumulative overall survival was calculated by Kaplan-Meier curve. Bivariat and multivariat analysis was done with Cox Proportional Hazards Regression Model to obtain Hazard Ration (HR) of each prognostic factor. Prognosis score from each mortality-related factor was calculated based on the last regression model.

Results: 181 from 402 patients were enrolled in this study with male proportion was 58.6% and patients aged 50 years or above was 57.5%. Sepsis (HR 2.462 ; CI 95% 1.552 ? 3.906), unsuccessful / no prior billiary drainage (HR 1.604 ; CI 95% 0.988 ? 2.603), and Charlson comorbid score ≥ 4 (HR 2.476 ; CI 95% 1.562 ? 3.923) were mortality-related factors with significant difference. Patients with significant prognostic factors had median survival 14 days; 95% CI: 9.66 ? 18.34 compared with overall median survival 26 days; 95% CI: 20.82 ? 31.19 (p < 0.01). Score ≥ 2 identified as the highest prognostic score threshold with sensitivity 68%, specificity 75%, and AUC on ROC curve 0.769.

Conclusion: Patients with significant prognostic factors which were sepsis, unsuccessful / no prior billiary drainage, and Charlson comorbid score ≥ 4 had shorter survival than overall survival. Prognostic threshold ≥ 2 quite good to classify malignant obstructive jaundice inpatient into high risk mortality population. Mortality of patients with those significant prognostic factors can be predicted in 76,9%."

"Obstructive: jaundice represents the most common complication of biliary tract Malignancy. Obstructive jaundice causes releases of proinflammatory cytokine. There has been controversy about effect of biliary drainage on the change in proinflammatory cytokine level in pancreatobiliary cancer patients. The present study was designed to determine levels of tumor necrosis factor alpha (TNF-alfa) and interleukin 6 (IL-6) in preprocedure of either endoscopic retrograde cholangio pancreatography (ERCP) or percutaneous transhepatic biliary drainage (PTBD) and postprocedure of them in obstructive jaundice patient caused by pancreatobiliary cancer.Method: The study method was before-and-after case study design with consecutive sampling. Blood was collected five days prior to either endoscopic retrograde cholangio pancreatography (ERCP) procedure or percutaneus transhepatic biliary drainage (PTBD) procedure and five days after either of them. Enzyme linked immunosorbed assay (ELISA) was used to determine TNF-alfa and IL-6.Results: Forty subjects were included in this study which consisted of 22 men and 18 women. The age was 55.3 (SD 13.7) years old. According to the results of imaging and endoscopy procedure, twenty-two people were diagnosed cholangicarcinoma, ten people were diagnosed ampulla vateri and eigth people were diagnosed pancreatic tumor. In preprocedure, the TNF-alfa concentration was 4.81 (SD 2.91) pg/mL, the IL-6 concentration was 7.79 (SD 1.57) pg/mL and the bilirubin concentration was 15.5 (SD 6,9) mg%. In postprocedure, the TNF-alfa concentration was 8.05 (SD 6.7) pg/mL, there was a significant increase in TNF-alfa concentration (p = 0.02). However, IL-6 concentration was 7.75 (SD 1.76) pg/mL, there was not any significant chance in IL-6 concentration (p = 0.52). The bilirubin concentration was 11.3 (SD 6,5) mg%.Conclusion: There was a significant increase in mean concentration value of TNF-alfa after biliary drainage procedure. On the other hand there was not any significant decrease in the mean concentration value of IL-6 after biliary drainage procedure"

"Meningkatnya penggunaan narkoba (narkotika, psikotropika dan berbahaya lainnya) di dunia, berdampak pada penyalahgunaan Methamphetamin (METH) khususnya di Indonesia. Efek METH dapat menginduksi neurotoksik, dimana terjadi kerusakan pada saraf terminal dopaminergik, serotonergik, apoptosis neuron, astroglia dan aktivasi mikroglia yang mengarah pada respon peradangan saraf di dalam otak. Studi menunjukkan efek NAC yang signifikan dalam memperbaiki TNF-α dan IL-6 pada fase infeksi akut atau kronis memotivasi pelaksanaan penelitian untuk mengevaluasi perubahan kadar IL-6 dan TNF-α pada pasien ketergantungan METH yang mengalami withdrawal pada kelompok yang mendapatkan terapi N- asetilsistein.Penelitian ini menggunakan bahan biologis tersimpan (serum), untuk mengetahui kadar IL-6 dan kadar TNF-α sebagai indikator neuroinflamasi pada pasien dengan ketergantungan METH yang mendapatkan terapi NAC (n=30) atau Placebo (n=30) selama 30 hari (cross-sectional). Penelitian dilakukan di Laboratorium Farmakologi Kinetik FKUI Salemba, Jakarta Pusat dan waktu penelitian pada bulan Agustus 2022 sampai bulan November 2022 dengan menggunakan metode ELISA. Hasil penelitian didapatkan 15 sampel yang terukur dan hanya 7 sampel yang dapat dianalisis (NAC-Placebo, Pre-Post Intervensi). Hasil mean TNF-α (Pre NAC) = 78.403 (pg/ml) ± 108,02, dan mean TNF-α (Post NAC) = 55,3176 (pg/ml) ± 75,15. Hasil IL-6 didapatkan pre NAC= 13,52 pg/ml, dan post NAC= 7,57 pg/ml. Kesimpulan penelitian adalah kadar IL-6 pada kelompok yang mendapatkan NAC mengalami penurunan dan kadar TNF-α pada kelompok yang mendapat NAC mengalami penurunan. Saran untuk penelitian selanjutnya diperlukan sampel baru dengan subyek yang lebih banyak dengan parameter inflamasi lainnya, dan kit-reader yang sensitif untuk mendapatkan efek potensial anti-inflamasi NAC pada subyek ketergantungan METH.

---

The increasing use of drugs (narcotics, psychotropics and other dangerous drugs) in the world has had an impact on the abuse of Methamphetamine (METH), especially in Indonesia. The effects of METH can induce neurotoxicity, where there is damage to dopaminergic, serotonergic nerve terminals, neuronal apoptosis, astroglia and activation of microglia which leads to a neuroinflammatory response in the brain. The study shows the significant effect of NAC in improving TNF-α and IL-6 in the acute or chronic phase of infection motivating the implementation of research to evaluate changes in IL-6 and TNF-α levels in METH-dependent patients experiencing withdrawal in the group receiving N-acetylcysteine ​​therapy .

This study used stored biological material (serum), to determine IL-6 levels and TNF-α levels as indicators of neuroinflammation in patients with METH dependence who received NAC therapy (n=30) or Placebo (n=30) for 30 days (cross -sectional). The research was conducted at the Kinetic Pharmacology Laboratory, FKUI Salemba, Central Jakarta and the research period was from August 2022 to November 2022 using the ELISA method.

The research results showed that 15 samples were measurable and only 7 samples could be analyzed (NAC-Placebo, Pre-Post Intervention). Results mean TNF-α (Pre NAC) = 78.403 (pg/ml) ± 108.02, and mean TNF-α (Post NAC) = 55.3176 (pg/ml) ± 75.15. IL-6 results showed that pre NAC= 13.52 pg/ml, and post NAC= 7.57 pg/ml. The conclusion of the study was that IL-6 levels in the group that received NAC decreased and TNF-α levels in the group that received NAC decreased. Suggestions for further research require new samples with more subjects with other inflammatory parameters, and sensitive kit-readers to obtain the potential anti-inflammatory effect of NAC in METH-dependent subjects."

"Hiperbilirubinelnia merupakan fenomena klinis yang sering ditemukan pada bayibaru lahir. Tujuan penelitian untuk mengidentifikasi pengaruh perubahan posisitidur selama fototerapi terhadap rata-rata kadar bilirubin total. Desain penelitianadalah quasi experimental pre-post test with control group. Sampel yangdigunakan yaitu bayi baru lahir dengan hiperbilirubinemia, terdiri atas 20 bayikelompok intervensi dan 20 bayi kelompok kontrol. Analisis perbedaan kadarbilirubin total menggunakan independent t test. Hasil penelitian menunjukkantidak ada perbedaan yang bermakna pada kadar bilirubin total kelompok kontroldan kelompok intervensi, namun penurunan kadar biliiubin pada kelompokintervensi lebih cepat dari pada kelompok kontrol. Penelitian inimerekomendasikan perubahan posisi tidur dapat mempercepat penurunan kadarbilirubin total.

---

AbstractHyperbilirubinemia is a clinical phenomenon that mostly appears to the newbornbaby. The purpose of the research is to identify the effect of changing sleepingposition during the phototherapy on the rate of total concentrate of bilirubin. Theresearch design was quasi experimental pre-post test with control group. Thesampel, was new born babies with hyperbilirubinemia; which were classified into20 babies in intervention group and 20 babies in controlled group. The analysis ofdifferent total bilirubin rate used independent t test showed that there was no anysignificant differences on the total of bilirubin rate in controlled group andintervention group. However, the total bilirubin rate reduction on the interventiongroup was faster than control group. This research reccomended that sleepingposition changes can decrease the total bilirubin rate fastly."